Infliximab as a steroid-sparing agent in refractory cutaneous sarcoidosis: Single-center retrospective study of 9 patients - 14/01/12
Doi : 10.1016/j.jaad.2011.05.040
Thomas Sené, MD a, Caroline Juillard, MD, MSc a, Michel Rybojad, MD a, Florence Cordoliani, MD a, Céleste Lebbé, MD, PhD a, Patrice Morel, MD a, Abdellatif Tazi, MD, PhD b, Fabien Guibal, MD, MSc a, ⁎ 
a Department of Dermatology, Hôpital Saint-Louis, Paris, France
b Department of Pneumology, Hôpital Saint-Louis, Paris, France
Correspondence to: Fabien Guibal, MD, MSc, Department of Dermatology, Hôpital Saint-Louis, 1 Avenue Claude-Vellefaux, 75475, Paris Cedex 10, France| Funding sources: None. |
|
| Conflicts of interest: None declared. |
© 2011
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 66 - N° 2
P. 328-332 - febbraio 2012 Ritorno al numero
Articolo precedente
- Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani
- Erwin Suys
- Grover disease may result from the impairment of keratinocytic cholinergic receptors
- David Paslin
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?